Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Paul Kent, a computational nanoscience researcher in ORNL’s Computing and Computational Science Directorate, received the ORNL Director’s Award for Outstanding Individual Accomplishment in Science and Technology. The award recognizes Kent’s leadership in quantum simulation development and application on high-performance computing platforms to help solve major scientific problems.
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Oak Ridge National Laboratory researchers proved that the heat transport ability of lithium-ion battery cathodes is much lower than previously determined, a finding that could help explain barriers to increasing energy storage capacity and boosting performance.
There are more than 17 million veterans in the United States, and approximately half rely on the Department of Veterans Affairs for their healthcare.